Igal Hayon-Louria
Haifa, HA 31096, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Cannabigerol (CBG) Modulates Neutrophil Activity and Ameliorates Rheumatoid Arthritis Pathogenesis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 04, 2026
Lnk Governs chemokine-directed trafficking of CD8+ T cells in melanoma.
Journal: Molecular therapy. Oncology
Published: December 16, 2025
Chronic cannabis use in breast cancer survivors: A questionnaire study of Israeli patients.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: May 06, 2025
High CBD extract (CBD-X) modulates inflammation and immune cell activity in rheumatoid arthritis.
Journal: Frontiers in immunology
Published: March 24, 2025
High-CBD Extract (CBD-X) in Asthma Management: Reducing Th2-Driven Cytokine Secretion and Neutrophil/Eosinophil Activity.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 10, 2024
Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions.
Journal: Rambam Maimonides medical journal
Published: November 02, 2023
Antitumoral effects of cannabis in Notch1-mutated T-cell acute lymphoblastic leukemia.
Journal: Cancer communications (London, England)
Published: October 24, 2022
High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs.
Journal: Frontiers in immunology
Published: February 14, 2022
The Immunopathology of COVID-19 and the Cannabis Paradigm.
Journal: Frontiers in immunology
Published: November 19, 2020
The heterogeneity and complexity of Cannabis extracts as antitumor agents.
Journal: Oncotarget
Published: March 23, 2019
Grb2 regulates the proliferation of hematopoietic stem and progenitors cells.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: October 27, 2016
Last Updated: 09/26/2026